Enzymatically cross-linked bovine lactoferrin as injectable hydrogel for cell delivery

Tissue Engineering - Part A

Volumn 20, Issue 21-22, 2014, Pages 2830-2839

  Amini, Ashley A ^a   Kan, Ho Man ^b   Cui, Zhanwu ^b   Maye, Peter ^a   Nair, Lakshmi S ^b,c,d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d University of Connecticut   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BONE; CELLS; HYDROGELS; MAMMALS; SILICATE MINERALS;

BOVINE LACTOFERRIN; CELL DELIVERY VEHICLES; HORSE-RADISH PEROXIDASE; INJECTABLE HYDROGELS; OSTEOBLAST PROLIFERATION; OSTEOCLASTOGENESIS; OSTEOGENIC DIFFERENTIATION; PROTEIN PHOSPHORYLATION;

CYTOLOGY;

ASPARTIC ACID; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CADHERIN; FIBROBLAST GROWTH FACTOR; GLUTAMIC ACID; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; LACTOFERRIN; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TYRAMINE; TYROSINE; VASCULOTROPIN; VASCULOTROPIN A; WNT PROTEIN; CROSS LINKING REAGENT; HYDROGEL;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BONE MARROW STROMA CELL; BONE REGENERATION; BONE TURNOVER; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL FUNCTION; CELL GROWTH; CELL INTERACTION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; ENZYME PHOSPHORYLATION; FLUORESCENCE; GELATION; GENE EXPRESSION; GLYCOGEN METABOLISM; HYDROGEL; MINERALIZATION; MITOGENESIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REACTION TIME; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BONE DEVELOPMENT; BOVINE; CELL SIZE; CHEMISTRY; CYTOLOGY; INJECTION; MATERIALS TESTING; PHYSIOLOGY; PROCEDURES; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSGENIC MOUSE;

ANIMALS; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; CROSS-LINKING REAGENTS; HYDROGELS; INJECTIONS; LACTOFERRIN; MATERIALS TESTING; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84909974434     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0506     Document Type: Article

References (36)

1. Gonzalez-Chavez, S.A., Arevalo-Gallegos, S., and Rascon-Cruz, Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 33, 301.e1, 2009.
2. Cornish, J., and Naot, D. Lactoferrin as an effector molecule in the skeleton. Biometals 23, 425, 2010.
3. Cornish, J., Palmano, K., Callon, K.E., Watson, M., Lin, J.M., Valenti, P., Naot, D., Grey, A.B., and Reid, I.R. Lactoferrin and bone; structure-activity relationships. Bio-chem Cell Biol 84, 297, 2006.
4. Naot, D., Grey, A., Reid, I.R., and Cornish, J. Lactoferrin-A novel bone growth factor. Clin Med Res 3, 93, 2005.
5. Grey, A., Zhu, Q., Watson, M., Callon, K., and Cornish, J. Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway. Mol Cell Endocrinol 251, 96, 2006.
6. Cornish, J. Lactoferrin promotes bone growth. Biometals 17, 331, 2004.
7. Cornish, J., Callon, K.E., Naot, D., Palmano, K.P., Banovic, T., Bava, U., Watson, M., Lin, J.M., Tong, P.C., Chen, Q., Chan, V.A., Reid, H.E., Fazzalari, N., Baker, H.M., Baker, E.N., Haggarty, N.W., Grey, A.B., and Reid, I.R. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145, 4366, 2004.
8. Amini, A.A., and Nair, L.S. Evaluation of the bioactivity of recombinant human lactoferrin towards murine preosteoblast cells. Tissue Eng Part A 19, 1047, 2012.
9. Takayama, Y., and Mizumachi, K. Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells. J Biosci Bioeng 107, 191, 2009.
10. James, E., and Nair, L.S. Development and characterization of lactoferrin loaded poly(e-caprolactone) nanofibers. J Biomed Nanotechnol 10, 500, 2014.
11. Takaoka, R., Hikasa, Y., Hayashi, K., and Tabata, Y. Bone regeneration by lactoferrin released from a gelatin hydro-gel. J Biomater Sci Polym Ed 22, 1581, 2011.
12. Naot, D., Chhana, A., Matthews, B.G., Callon, K.E., Tong, P.C., Lin, J.M., Costa, J.L., Watson, M., Grey, A.B., and Cornish, J. Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. Bone 49, 217, 2011.
13. Grey, A., Banovic, T., Zhu, Q., Watson, M., Callon, K., Palmano, K., Ross, J., Naot, D., Reid, I.R., and Cornish, J. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 18, 2268, 2004.
14. Kurisawa, M., Chung, J.E., Yang, Y.Y., Gao, S.J., and Uyama, H. Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun (Camb) 34, 4312, 2005.
15. Kobayashi, S., Uyama, H., and Kimura, S. Enzymatic polymerization. Chem Rev 101, 3793, 2001.
16. Jin, R., Hiemstra, C., Zhong, Z., and Feijen, J. Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomaterials 28, 2791, 2007.
17. Amini, A.A., and Nair, L.S. Enzymatically crosslinked gelatin gel as osteoblast delivery vehicle. J Bioact Compat Polym 27, 342-355, 2012.
18. Lee, F., Chung, J.E., and Kurisawa, M. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. J Control Release 134, 186, 2009.
19. Sakai, S., Yamada, Y., Zenke, T., and Kawakami, K. Novel chitosan derivative soluble at neutral pH and in-situ gel-lable via peroxidase-catalyzed enzymatic reaction. J Mater Chem 19, 230, 2009.
20. Maye, P., Stover, M.L., Liu, Y., Rowe, D.W., Gong, S., and Lichtler, A.C. A BAC-bacterial recombination method to generate physically linked multiple gene reporter DNA constructs. BMC Biotechnol 9, 20, 2009.
21. Amini, A.A., and Nair, L.S. Evaluation of the osteogenic activity of injectable bovine lactoferrin gel. Proceedings of the 2011 Annual Meeting of the Society for Biomaterials. Soc Biomater 2011.
22. Amini, A.A., and Nair, L.S. Characterization of recombi-nant human lactoferrin gel as an injectable osteogenic biomaterial. Proceedings of the TERMIS-NA annual conference, 2011. Tissue Eng Int Regen Med Soc 2011.
23. van Berkel, P.H., Welling, M.M., Geerts, M., van Veen, H.A., Ravensbergen, B., Salaheddine, M., Pauwels, E.K., Pieper, F., Nuijens, J.H., and Nibbering, P.H. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol 20, 484, 2002.
24. van Berkel, P.H., van Veen, H.A., Geerts, M.E., and Nuijens, J.H. Characterization of monoclonal antibodies against human lactoferrin. J Immunol Methods 267, 139, 2002.
25. Amini, A.A., and Nair, L.S. Lactoferrin: a biologically active molecule for bone regeneration. Curr Med Chem 18, 1220, 2011.
26. th ORS annual meeting. Orthop Res Soc 2011.
27. Nakajima, K.I., Kanno, Y., Nakamura, M., Gao, X.D., Kawamura, A., Itoh, F., and Ishisaki, A. Bovine milk lac-toferrin induces synthesis of the angiogenic factors VEGF and FGF2 in osteoblasts via the p44/p42 MAP kinase pathway. Biometals 24, 847, 2011.
28. Bouillon, R. Growth hormone and bone. Horm Res 36 Suppl 1, 49, 1991.
29. Baumrucker, C.R., Gibson, C.A., and Schanbacher, F.L. Bovine lactoferrin binds to insulin-like growth factor-binding protein-3. Domest Anim Endocrinol 24, 287, 2003.
30. Arnsdorf, E.J., Tummala, P., and Jacobs, C.R. Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS One 4, e5388, 2009.
31. Ying, X., Cheng, S., Wang, W, lin, Z, Chen, Q., Zhang, W., Kou, D., Shen, Y., Cheng, X., Peng, Lei., Xu, H.Z., and Lu, C.Z. Effect of lactoferrin on osteogenic differentiation of human adipose stem cells. Int Orthop 36, 647, 2012.
32. Hajduch, E., Litherland, G.J., and Hundal, H.S. Protein kinase B (PKB/Akt)-A key regulator of glucose transport? FEBS Lett 492, 199, 2001.
33. Nave, B.T., Ouwens, M., Withers, D.J., Alessi, D.R., and Shepherd, P.R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344Pt 2, 427, 1999.
34. Lo, A.T., Mori, H., Mott, J., and Bissell, M.J. Constructing three-dimensional models to study mammary gland branching morphogenesis and functional differentiation. J Mammary Gland Biol Neoplasia 17, 103, 2012.
35. Cohen, D.M., and Chen, C.S. Mechanical control of stem cell differentiation. StemBook 2008. DOI: 10.3824/stem-book.1.26.1.
36. Amini, A.A., and Nair, L.S. Injectable hydrogels for bone and cartilage repair. Biomed Mater 7, 024105, 2011.